cytotox
cell
ctl
respons
necessari
lysi
viral
infect
cell
control
infect
ctl
activ
tcr
bind
major
histocompat
complex
mhc
ipeptid
complex
surfac
antigen
present
cell
macrophag
appar
display
remark
plastic
respons
environment
signal
polar
classic
activ
lp
altern
activ
howev
littl
known
activ
statu
influenc
antigen
present
function
cell
model
viru
infect
consequ
test
polar
spleenderiv
sp
impact
direct
present
viral
antigen
influenc
effector
prolif
tcell
respons
show
retain
mhci
surfac
express
abil
stimul
product
ctl
follow
peptid
stimul
lymphocyt
choriomening
viru
infect
level
similar
lp
howev
memori
cell
cultur
presenc
underw
significantli
reduc
prolifer
produc
similar
level
cocultur
lp
cell
thu
result
show
novel
abil
polar
regul
tcell
prolifer
effector
function
viru
infect
introduct
tissu
macrophag
compris
import
member
mononuclear
phagocyt
system
regul
inflamm
cancer
autoimmun
involv
innat
adapt
immun
respons
invad
pathogen
adapt
phenotyp
function
accord
environ
process
term
polar
understood
tissu
bone
marrow
bm
develop
proinflammatori
antiinflammatori
lp
activ
occur
respons
interferongamma
combin
bacteri
moieti
lipopolysaccharid
lp
lp
exhibit
elev
secret
level
nitric
oxid
proinflammatori
cytokin
includ
tumor
necrosi
factor
tnf
phenotyp
lp
cell
express
major
role
histocompat
complex
mhc
ii
costimulatori
molecul
stimul
tcell
prolifer
lp
cell
studi
antibacteri
antivir
immun
hand
cell
subdivid
depend
environment
stimulu
studi
subclass
induc
interleukin
upregul
express
express
high
level
mannos
receptor
protein
wide
consid
regulatori
repar
cell
howev
uncheck
expans
caus
sever
patholog
exampl
chronic
hepat
c
viru
hcv
infect
circul
liver
monocyt
convert
state
result
fibrosi
develop
therefor
import
studi
polar
viru
infect
strategi
unlock
target
therapeut
limit
virusassoci
damag
lymphocyt
choriomening
viru
infect
lcmv
support
viral
replic
process
present
viral
antigen
activ
cell
activ
cell
prolifer
gradual
acquir
cytotox
lymphocyt
ctl
effector
function
home
site
infect
secret
lyse
viral
infect
upon
recognit
viral
epitop
mhci
known
periton
inhibit
otii
prolifer
signal
transduc
activ
transcript
stat
fashion
moreov
murin
noroviru
infect
model
helminthinduc
cell
inhibit
tcell
prolifer
yet
polar
engag
cell
control
prolifer
function
rna
viru
infect
remain
unexplor
report
novel
find
support
dichotom
regulatori
role
tissu
inhibit
tcell
prolifer
without
affect
product
peptidespecif
antigen
present
phenotyp
function
character
activ
spleenderiv
sp
nitrit
urea
product
known
effect
function
measur
lp
polar
respect
therefor
demonstr
plastic
character
biochem
properti
profil
polar
follow
h
lp
h
stimul
h
agreement
previou
public
induc
signific
nitrit
product
lp
stimul
condit
figur
left
panel
produc
urea
follow
treatment
figur
right
panel
confirm
previou
publish
data
thu
tissuederiv
show
similar
biochem
profil
polar
lp
statu
report
previous
profession
antigen
present
cell
papc
need
activ
adapt
immun
cell
involv
antigen
present
via
mhci
mhcii
well
express
costimulatori
molecul
nevertheless
lcmv
evolv
mechan
interrupt
apc
activ
costimulatori
molecul
express
therefor
order
assess
abil
polar
engag
tcell
receptor
character
surfac
express
activ
marker
follow
h
lcmv
infect
figur
regard
express
lp
cell
increas
surfac
level
follow
viral
infect
cell
express
remain
larg
unchang
column
interestingli
cell
slightli
decreas
express
follow
lcmv
infect
compar
lp
cell
chang
detect
column
cell
exhibit
slight
mhci
reduct
lp
column
addit
also
assess
express
inhibitori
molecul
column
observ
lp
cell
express
greatest
level
similar
express
level
confirm
data
publish
anoth
group
lcmv
infect
increas
express
reduc
express
lp
data
demonstr
polar
cell
neg
affect
lcmv
infect
consid
mhci
express
lcmv
increas
inhibitori
molecul
express
cell
lp
character
function
profil
polar
cell
investig
releas
proand
antiinflammatori
cytokin
uninfect
lcmvinfect
h
expect
secret
cytokin
figur
cell
poor
lp
stimul
produc
substanti
level
agre
describ
previous
interestingli
h
postlcmv
infect
cell
significantli
increas
product
moreov
lp
cell
reduc
product
infect
still
produc
significantli
higher
amount
chang
secret
observ
lp
infect
lymphocyt
choriomening
viru
infect
significantli
decreas
product
lp
cell
opposit
true
product
level
increas
collect
data
point
lcmvpromot
cell
acquir
mix
lp
phenotyp
consid
abil
produc
proinflammatori
cytokin
postinfect
antiinflammatori
cytokin
lcmv
infect
increas
secret
subset
howev
lp
produc
substanti
less
amount
infect
cell
figur
bound
mhci
lower
level
compar
lp
c
cell
puls
siinfekl
h
coincub
tcell
hybridoma
h
ratio
detect
assay
carri
describ
section
materi
method
od
measur
nm
graph
depict
mean
sd
three
experiment
replic
mfi
mean
fluoresc
intens
mhc
major
histocompat
complex
figur
demonstr
popul
abl
display
p
mhc
surfac
measur
fold
chang
mean
fluoresc
intens
mfi
unpuls
control
reveal
lp
best
bind
present
peptid
spm
cell
least
effici
figur
suggest
polar
subset
abl
present
b
restrict
epitop
cell
vari
degre
base
observ
figur
b
reason
would
translat
differenti
abil
activ
cell
popul
test
employ
tcell
hybridoma
system
induc
lacz
nfat
enhanc
bind
promot
system
siinfeklk
b
specif
tcr
ligat
result
bind
promotor
express
downstream
lacz
detect
colorimetr
chang
use
two
differ
concentr
siinfekl
peptid
observ
lp
popul
elicit
activ
better
figur
yet
still
profici
activ
cell
indic
cell
retain
suffici
antigen
present
capabl
close
cell
recent
shown
splenic
margin
zone
respons
activ
lcmvspecif
cell
left
unprim
dc
therefor
extend
test
lcmv
system
includ
b
b
bind
epitop
b
mice
polar
puls
either
cocultur
splenocyt
isol
lcmvinfect
mice
pfu
ip
day
postinfect
abil
virusspecif
cell
produc
vitro
restimul
ic
assay
use
assess
polar
antigen
present
function
figur
found
percentag
antigenspecif
cell
remain
constant
irrespect
activ
statu
figur
b
moreov
agreement
immunodomin
hierarchi
report
model
greater
percentag
cell
cell
figur
b
find
ident
irrespect
activ
state
even
lowpeptid
concentr
test
induct
lcmvmemoryspecif
cell
use
lcmv
peptid
ex
vivo
stimul
puls
found
cell
abl
elicit
similar
activ
memori
cell
compar
data
shown
therefor
abl
demonstr
polar
neg
influenc
abil
stimul
activ
releas
antigenspecif
effector
memori
cell
viru
infect
assess
whether
function
abil
regard
antigen
present
retain
viral
infect
infect
lcmv
moi
assess
abil
present
lcmv
antigen
epitopespecif
ctl
clear
data
figur
lcmv
infect
polar
vitro
initi
replic
cycl
evid
lcmvnp
detect
h
postinfect
figur
protein
detect
immedi
first
hour
present
cell
interact
cell
discov
profici
present
either
peptid
process
viral
antigen
differ
model
system
inhibit
antigenspecif
tcell
prolifer
public
util
cultur
system
cell
specif
antitcr
antibodi
artifici
stimul
tcell
prolifer
antigenindepend
fashion
prolifer
howev
cell
direct
memori
recal
respons
unknown
therefor
ask
cell
lcmv
memori
nontransgen
mice
would
respond
antigen
present
polar
assess
cultur
peptidepuls
either
polar
unstimul
carboxyfluorescein
succinimidyl
ester
cfse
label
splenocyt
lcmv
immun
wt
mice
absenc
presenc
figur
b
without
exogen
ad
cultur
three
popul
fail
induc
recal
prolifer
vitro
data
shown
confirm
previous
publish
data
group
increas
cultur
concentr
determin
minimum
threshold
exogen
requir
tcell
expans
uml
lp
induc
tcell
prolifer
respect
figur
b
contrast
induc
lowest
prolifer
antigenspecif
cell
figur
b
abl
restor
deficit
stimul
abil
cell
increas
level
cultur
system
uml
find
restrict
singl
specif
epitopespecif
cell
cell
prolifer
similar
level
compar
either
lp
figur
collect
data
cell
expand
day
stimul
exhibit
attenu
secret
compar
lp
cell
observ
note
although
tcell
prolifer
impair
compar
approxim
cell
still
prolifer
peptid
antigen
present
figur
cell
prolifer
progress
acquir
ctl
function
test
whether
epitopespecif
cell
fulli
function
expans
period
restimul
expand
cell
use
common
bma
cell
line
antigen
present
cell
variabl
factor
assay
would
expans
differ
consequ
cocultur
cell
vitro
day
use
uml
concentr
observ
minim
induc
ctl
expans
figur
test
product
ic
describ
earlier
time
use
bma
cell
line
apc
present
lcmv
peptid
cell
figur
lp
expand
ctl
posit
wherea
expand
ctl
display
lower
level
puls
lcmv
cultur
cfselabel
splenocyt
lcmv
immun
mice
ratio
day
presenc
uml
uml
b
expand
cell
restimul
puls
bma
unpuls
control
detect
product
ic
restimul
assay
detect
epitopespecif
activ
graph
show
mean
sd
three
replic
p
p
cfse
carboxyfluorescein
succinimidyl
ester
lcmv
lymphocyt
choriomening
viru
infect
figur
day
cocultur
cell
test
cfse
dilut
describ
cfse
carboxyfluorescein
succinimidyl
ester
lcmv
lymphocyt
choriomening
viru
infect
evid
suggest
effici
tcell
respons
occur
apc
must
help
cell
particular
direct
engag
activ
apc
enabl
product
memori
tcell
prolifer
given
rescu
tcell
prolifer
cultur
experiment
model
reason
activ
vivo
lcmv
infect
would
compens
abil
support
cell
model
exogen
level
limit
cultur
test
hypothesi
sort
cell
lcmvinfect
mice
day
shown
express
level
near
peak
viru
infect
vivo
cocultur
sort
cell
plu
cell
cfse
prolifer
assay
model
exogen
level
limit
although
observ
addit
cell
enhanc
abil
cell
increas
tcell
prolifer
posit
influenc
cultur
figur
possibl
may
requir
addit
help
interestingli
prolifer
note
lp
cell
includ
helper
cell
indic
possibl
maximum
prolifer
alreadi
reach
level
without
cell
present
cultur
understood
polar
modul
outcom
infect
play
role
exacerb
combat
multipl
diseas
previous
report
mcsf
induc
vitro
differenti
cell
resembl
splenic
red
pulp
character
reveal
effect
antigen
present
cell
capabl
direct
cross
present
addit
matur
remain
plastic
induc
lp
phenotyp
similar
sever
group
report
abil
polar
cell
neg
regul
cell
addit
polar
bm
cell
shown
inhibit
tcell
prolifer
impair
prolifer
lcmvspecif
transgen
cell
helminthnoroviru
coinfect
model
howev
much
known
regard
polar
influenc
antigenspecif
tcell
secret
memori
tcell
recal
respons
antigen
present
ensu
particularli
viral
infect
end
use
welldefin
lcmv
model
studi
uncov
dichotom
moreov
larginin
depriv
yield
arrest
prevent
increas
cyclin
cyclindepend
kinas
level
thu
cell
abil
modul
tcell
prolifer
contactdepend
contactindepend
mechan
system
observ
signific
reduct
antigenspecif
memori
tcell
prolifer
stimul
cell
compar
lp
employ
limit
concentr
interestingli
supplement
cocultur
medium
addit
restor
tcell
prolifer
subsequ
secret
upon
restimul
like
explan
find
like
due
abil
tune
tcr
sensit
regul
cellcycl
progress
regard
tcr
sensit
exogen
restor
basal
depress
express
patient
chronic
myeloid
leukemia
moreov
recent
demonstr
reduc
threshold
activ
cell
promot
respons
low
antigen
level
therefor
ad
ostens
improv
tcr
sensit
antigen
term
cell
cycl
enhanc
express
cyclin
activ
promot
cellcycl
progress
phase
therefor
plausibl
addit
overrid
cellinduc
tcell
impair
increas
express
promot
entranc
cell
cycl
agreement
notion
deliveri
complex
monoclon
antibodi
break
establish
tcell
toler
fbl
model
murin
leukemia
futur
research
biolog
mechan
report
novel
find
overcom
stimulatori
deficit
cell
immens
interest
immunotherapi
field
anoth
novel
find
report
abil
polar
elicit
product
antigenspecif
ctl
follow
peptid
stimul
lcmv
infect
given
impair
tcell
tcr
signal
describ
follow
cocultur
anticip
cell
poorli
induc
secret
ctl
limit
studi
address
consequ
shortterm
h
interact
express
howev
durat
cytokin
detect
assay
approxim
h
allow
us
separ
shortterm
longterm
impact
cell
tcell
effector
function
memori
tcell
prolif
respons
system
observ
abil
cell
stimul
ctl
releas
like
attribut
lower
threshold
ctl
activ
cytokin
product
compar
prolifer
previous
demonstr
low
concentr
tcr
ligand
result
product
prolifer
cell
howev
ligand
concentr
increas
divers
cytokin
respons
prolifer
level
impli
addit
characterist
polyfunct
cell
requir
success
increas
signal
threshold
conceptu
might
serv
safeguard
control
unwant
tcell
effector
activ
cytokin
product
summari
result
uncov
previous
unknown
abil
cell
induc
secret
ctl
yet
neg
regul
memori
tcell
prolifer
compar
form
employ
studi
thu
plausibl
cell
possess
novel
undefin
characterist
need
uncov
regard
may
regul
immun
infect
b
mice
week
purchas
jackson
laboratori
kept
specif
pathogenfre
condit
anim
experi
carri
accord
guidelin
canadian
council
anim
use
approv
queen
univers
anim
care
committe
bma
cell
line
gift
dr
k
rock
univers
massachusett
medic
school
worcest
usa
adher
murin
cell
line
gener
bm
femal
mice
overexpress
myc
raf
oncogen
recent
character
group
good
model
studi
polar
viral
infect
mice
inject
indic
plaqu
form
unit
pfu
lcmvwe
intraperiton
steril
pb
bone
gener
previous
describ
assess
arginas
induc
nitric
oxid
activ
lp
polar
determin
assess
product
use
griess
reagent
publish
previous
cellswel
seed
roundbottom
plate
activ
phenolr
free
rpmi
nitrit
concentr
determin
measur
od
nm
use
varioskan
micropl
reader
sodium
nitrit
use
standard
graph
calcul
nitrit
concentr
test
sampl
purchas
fisher
scientif
whitbi
canada
polar
assess
arginas
activ
describ
activ
resuspend
lysi
buffer
tritonx
triscl
ph
purchas
sigma
oakvil
canada
incub
min
follow
centrifug
g
min
protein
content
supernat
determin
use
bradford
reagent
bioshop
sampl
concentr
equal
reaction
sampl
ad
eppendorf
follow
incub
min
larginin
solut
ph
ad
incub
h
stop
reaction
acid
solut
ispf
wv
absolut
ethanol
ad
sampl
heat
min
urea
concentr
determin
help
urea
standard
graph
measur
od
nm
use
varioskan
spectrophotometr
micropl
reader
uninfect
lcmvinfect
moi
h
seed
cellsml
plate
incub
h
incub
elisa
perform
collect
supernat
level
measur
accord
r
system
manufactur
instruct
total
rna
extract
primari
lcmvinfect
cell
use
tri
reagent
molecular
research
center
inc
rt
reaction
carri
use
rt
master
mix
reagent
obtain
froggabio
north
york
canada
pcr
perform
use
taq
master
mix
froggabio
follow
primer
forward
revers
obtain
integr
dna
technolog
coravil
ia
usa
lcmv
nucleoprotein
f
atg
aga
gca
cag
tgc
ggg
gtg
r
tgg
gag
aac
acg
aca
att
gac
control
r
cell
stain
combin
surfac
marker
antibodi
detail
primari
direct
stain
perform
antibodi
purchas
biolegend
induct
lcmvspecif
cell
peptidespecif
shortterm
tcell
line
gener
previous
describ
splenocyt
isol
lcmv
immun
mice
day
postinfect
subject
ficollgradi
lymphocyt
enrich
enrich
cell
cocultur
peptideload
bma
ratio
rpmi
fc
uml
gentamycin
day
medium
isol
ficol
remov
dead
apc
enrich
cell
reseed
new
plate
fresh
medium
day
use
order
compar
direct
antigen
present
activ
util
lcmvspecif
cell
either
vitro
gener
lcmv
ctl
hybridoma
cell
ex
vivo
stimul
lcmvspecif
cell
polar
splenocyt
isol
lcmvinfect
mous
day
restimul
peptidepuls
ratio
splenocyt
apc
h
ic
product
perform
describ
lcmvspecif
ctl
cultur
activ
puls
decreas
peptid
molar
infect
lcmvwe
moi
assay
tcell
hybridoma
cell
line
specif
ova
residu
siinfekl
present
murin
mhci
b
also
use
cell
cultur
imdm
medium
contain
ensur
posit
select
report
cell
time
experi
antigen
present
assay
apc
puls
siinfekl
peptid
h
extens
wash
warm
pb
thereaft
apc
cocultur
roundbottom
plate
thermo
scientif
ratio
h
imdm
medium
fc
lazz
detect
z
buffer
contain
mm
onpg
ad
apc
cell
pellet
incub
h
allow
colorimetr
chang
thereaft
buffer
transfer
flatbottom
plate
absorb
measur
nm
use
varioskan
plate
reader
lcmvnp
detect
infect
cell
fix
permeabil
pb
contain
paraformaldehyd
saponin
min
room
temperatur
cell
wash
pb
saponin
incub
h
rat
antilcmvnp
ab
clone
supernat
gift
dr
groettrup
univers
constanc
germani
detect
np
express
wash
twice
fitcconjug
goat
antirat
igg
ab
invitrogen
incub
cell
overnight
separ
experi
propidium
idodid
sigma
aldrich
oakvil
canada
ad
uninfect
lcmvinfect
sampl
assess
cell
death
data
acquir
epic
xl
mcl
beckman
analyz
flowjo
softwar
vitro
prolifer
assay
splenocyt
harvest
lcmvwe
immun
day
postinfect
lymphocyt
purifi
ficollgradi
centrifug
lymphocyt
separ
medium
fisher
whitbi
canada
purifi
cell
label
cfse
min
wash
twice
warm
pb
lymphocyt
cultur
flatbottom
plate
peptid
puls
polar
day
decreas
concentr
recombin
stain
express
assess
cfse
stain
fcm
percent
prolifer
determin
calcul
cfse
low
cell
compar
unstimul
cfse
label
control
cfse
hi
tcell
cocultur
experi
cell
neg
select
gate
cell
spleen
use
bd
fac
aria
iii
sorter
beckmandickinson
cell
ad
cfse
label
splenocyt
indic
ratio
incub
day
statist
analysi
perform
use
prism
la
jolla
ca
usa
unpair
student
ttest
